Our Mission
▫ Medical professionals do not have access to in vitro (laboratory) tools to objectively diagnose, estimate clinical severity, and treat patients with genetic-based neurological disorders.
▫ This leads to a significant number of patients failing to obtain a diagnosis, waiting years to obtain a diagnosis, or spending years attempting to identity the proper therapeutic.
▫ NeuroDetect is developing machine learning-guided software that creates precision-guided biomarker profiles of patients suffering from genetic-based neurological disorders.
